Several years later, with a Summa Cum Laude in Nutrition, she moved to Germany and began her studies in medicine and completion of her M.D. degree in Innsbruck, Austria.

With a total of 40 years devoted to research, Dr. Flavin started the Foundation for Collaborative Medicine and Research in Connecticut, a non-profit organization where she shares her knowledge in the areas of medicine, pharmacology and nutrition with patients and colleagues from around the world.

Her medical success stories include the development of a new therapy for mononucleosis hepatosplenomegaly that reverses this disease in children in 24 hours (published in the Journal of Orthomolecular Medicine, 2006) and a therapy for breast cancer patients that reverses brain metastases within 3 months (published in the Journal of Neurooncology, 2007).

She continually searches for new therapies globally, both conventional and complementary. Her most recent work involves a highly developed nanotechnology (Quantum dot), a collaborative effort using a nanocrystal delivery system to carry compounds and amplify their activities. These nanocrystals only affect cancer mitochondria, thereby stopping the cancer and reversing the disease.

Her ongoing global education in science and medicine has also helped discover and improve therapies for many diseases including cancer, autoimmune diseases (such as Graves thyroiditis), rheumatoid arthritis and viral diseases.

Collaboration between Heidelberg Cancer Research Center and the USA is presently in development.

Dr. Flavin has devoted her life to help humankind in every way possible and relieve suffering, find treatments/solutions and bring back hope to the hopeless and health to those who were dying.

“I’ve been researching cancer since 1979. I started applying what I learned in 1992, and to my surprise, the tumors in my patients began to disappear. As I learned more methods, mechanisms and secret therapies over the years, I realized cancer is indeed reversible and no longer the enemy.” – Dr. Dana Flavin

With a total of 40 years devoted to research, Dr. Flavin started the Foundation for Collaborative Medicine and Research in Connecticut, a non-profit organization where she shares her knowledge in the areas of medicine, pharmacology and nutrition with patients and colleagues from around the world.

Her medical success stories include the development of a new therapy for mononucleosis hepatosplenomegaly that heals children in 24 hours (published in the Journal of Orthomolecular Medicine, 2006) and a therapy for breast cancer patients that reverses brain metastases within 3 months (published in the Journal of Neurooncology, 2007).

She continually searches for new therapies globally, both conventional and complementary. Her most recent work involves a highly developed nanotechnology (Quantum dot), a collaborative effort using a nanocrystal delivery system to carry compounds and amplify their activities. These nanocrystals only affect cancer mitochondria, thereby stopping the cancer and reversing the disease.

Her ongoing global education in science and medicine has also helped discover and improve therapies for many diseases including cancer, autoimmune diseases (such as Graves thyroiditis), rheumatoid arthritis and viral diseases.

Collaboration between Heidelberg Cancer Research Center and the USA is presently in development.

Dr. Flavin has devoted her life to help humankind in every way possible–relieving suffering, finding treatments/solutions to bring back hope to the hopeless and health to those who were dying.

“I’ve been researching cancer since 1979. I started applying what I learned in 1992, and to my surprise, the tumors in my patients began to disappear. As I learned more methods, mechanisms and secret therapies over the years, I realized cancer is indeed reversible and no longer the enemy.” – Dr. Dana Flavin